Article citationsMore>>

Ramdas, S., Hum, R.M., Price, A., Paul, A., Bland, J., Burke, G., et al. (2022) SARS-CoV-2 Vaccination and New-Onset Myasthenia Gravis: A Report of 7 Cases and Review of the Literature. Neuromuscular Disorders, 32, 785-789.
https://doi.org/10.1016/j.nmd.2022.09.001

has been cited by the following article:

• TITLE: Post-Vaccination Myasthenia Gravis and Vaquez Disease

  AUTHORS: Alassane Mamadou Diop, Ahmadou Bamba Mbodj, Daouda Thioub, Jamil Kawahgi, Maouly Fall

  KEYWORDS: SARS-CoV2, Myasthenia, JAK2

  JOURNAL NAME: Neuroscience and Medicine, Vol.16 No.2, June 25, 2025

  ABSTRACT: We report the case of a 68-year-old patient who developed autoimmune myasthenia 24 hours after receiving the second dose of an inactivated SARS-CoV-2 vaccine (Sinopharm®). This patient, already followed for ischemic heart disease, presented with typical symptoms such as diplopia, bilateral ptosis, and muscle fatigability upon exertion. Investigations revealed the presence of anti-acetylcholine receptor antibodies as well as polycythemia, confirmed by the JAK2 V617F mutation, suggesting an association with a myeloproliferative disorder.